RBFC
MEDP icon

Roman Butler Fullerton & Co’s Medpace MEDP Stock Holding History

Roman Butler Fullerton & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-821
Closed -$498K – 277
2025
Q4 		$498K Buy
+821
New +$466K 0.13% 168

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Roman Butler Fullerton & Co's MEDP Position: Q1 2026 in Review

Roman Butler Fullerton & Co sold out of Medpace (MEDP) in Q1 2026, closing a stake of 821 shares — an estimated $498K sold.

Roman Butler Fullerton & Co first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $498K in Q4 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Roman Butler Fullerton & Co reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 821 Medpace shares in Q1 2026, an estimated $498K.
  • Roman Butler Fullerton & Co first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
  • Roman Butler Fullerton & Co's Medpace position peaked at $498K in Q4 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2026, filed 30 Apr 2026.